Skip to main content
logo
Apontis Pharma AG (FRA:APPH)
Germany flag Germany · Delayed Price · Currency is EUR
10.70
+0.20 (1.90%)
Last updated: Oct 22, 2025, 8:00 AM CET

Apontis Pharma AG Revenue

Apontis Pharma AG had revenue of 26.03M EUR in the half year ending June 30, 2025, with 36.60% growth. This brings the company's revenue in the last twelve months to 51.77M, up 27.42% year-over-year. In the year 2024, Apontis Pharma AG had annual revenue of 48.47M with 31.12% growth.

Revenue (ttm)
51.77M
Revenue Growth
+27.42%
P/S Ratio
1.75
Revenue / Employee
377.91K
Employees
137
Market Cap
90.38M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202448.47M11.50M31.12%
Dec 31, 202336.96M-18.76M-33.67%
Dec 31, 202255.73M4.54M8.87%
Dec 31, 202151.18M11.94M30.44%
Dec 31, 202039.24M-794.91K-1.99%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Mercedes-Benz Group AG139.36B
Deutsche Telekom AG120.55B
Allianz SE109.02B
Siemens Aktiengesellschaft78.30B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München62.33B
Siemens Energy AG38.39B
SAP SE35.89B
Deutsche Bank Aktiengesellschaft30.07B
Revenue Rankings

Apontis Pharma AG News

More News